A Phase 4, Open-Label, Single-Dose Pharmacokinetic Study of a Novel Methylphenidate Extended-Release Orally Disintegrating Tablet Formulation in Preschool-Aged Children
2019 ◽
Vol 58
(10)
◽
pp. S298
2019 ◽
Vol 58
(10)
◽
pp. S292
◽
2020 ◽
Vol 30
(1)
◽
pp. 15-20
2018 ◽
Vol 57
(10)
◽
pp. S173-S174
Keyword(s):
2012 ◽
Vol 34
(1)
◽
pp. 201-213
◽
Keyword(s):
2019 ◽
Vol 57
(08)
◽
pp. 408-415
Keyword(s):
2017 ◽
Vol 39
(12)
◽
pp. 2389-2398
◽
Keyword(s):
2018 ◽
Vol 2018
◽
pp. 1-7
◽
Keyword(s):
Keyword(s):
Keyword(s):